Juergen Koester

2.4k total citations · 1 hit paper
16 papers, 1.7k citations indexed

About

Juergen Koester is a scholar working on Neurology, Epidemiology and Cognitive Neuroscience. According to data from OpenAlex, Juergen Koester has authored 16 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Neurology, 12 papers in Epidemiology and 4 papers in Cognitive Neuroscience. Recurrent topics in Juergen Koester's work include Parkinson's Disease Mechanisms and Treatments (12 papers), Restless Legs Syndrome Research (12 papers) and Parkinson's Disease and Spinal Disorders (5 papers). Juergen Koester is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (12 papers), Restless Legs Syndrome Research (12 papers) and Parkinson's Disease and Spinal Disorders (5 papers). Juergen Koester collaborates with scholars based in Germany, Finland and United States. Juergen Koester's co-authors include Mark Stacy, Valerie Voon, Daniel Weintraub, Jacqueline Whetteckey, Andrew Siderowf, Glen Wunderlich, Marc N. Potenza, Anthony E. Lang, Juergen Reess and Matthias Lemke and has published in prestigious journals such as Neurology, Movement Disorders and Allergy.

In The Last Decade

Juergen Koester

16 papers receiving 1.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Impulse Control Disorders in Parkinson Disease

2010 971 citations Daniel Weintraub, Juergen Koester et al. Archives of Neurology profile →

Peers

Countries citing papers authored by Juergen Koester

Since Specialization

Citations

This map shows the geographic impact of Juergen Koester's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Juergen Koester with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Juergen Koester more than expected).

Fields of papers citing papers by Juergen Koester

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Juergen Koester. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Juergen Koester. The network helps show where Juergen Koester may publish in the future.

Co-authorship network of co-authors of Juergen Koester

This figure shows the co-authorship network connecting the top 25 collaborators of Juergen Koester. A scholar is included among the top collaborators of Juergen Koester based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Juergen Koester. Juergen Koester is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

#	Work	Indexed citations
1	Assessment of rebound and relapse following ecallantide treatment for acute attacks of hereditary angioedema 2012 ·Allergy ·Jonathan A. Bernstein, Elizabeth P. Shea, Juergen Koester, Ryan Iarrobino, W.E. Pullman	10
2	Randomized trial of pramipexole for patients with restless legs syndrome (RLS) and RLS-related impairment of mood 2010 ·Sleep Medicine ·Pasquale Montagna, Magdolna Hornyak, Jan Ulfberg, Seung Bong Hong, Juergen Koester, (unknown), Stefan Albrecht	40
3	Impulse Control Disorders in Parkinson Disease breakdown → 2010 ·Archives of Neurology ·Daniel Weintraub, Juergen Koester, Marc N. Potenza, Andrew Siderowf, Mark Stacy, Valerie Voon, Jacqueline Whetteckey, Glen Wunderlich, Anthony E. Lang	971
4	A dose-ranging study of pramipexole for the symptomatic treatment of restless legs syndrome: Polysomnographic evaluation of periodic leg movements and sleep disturbance 2009 ·Sleep Medicine ·(unknown), Kari Hirvonen, Markku Partinen, Anniina Alakuijala, Christer Hublin, Ilkka Tamminen, Juergen Koester, Juergen Reess	34
5	Open-label study of the long-term efficacy and safety of pramipexole in patients with Restless Legs Syndrome (extension of the PRELUDE study) 2008 ·Sleep Medicine ·Markku Partinen, Kari Hirvonen, (unknown), Anniina Alakuijala, Christer Hublin, Ilkka Tamminen, Juergen Koester, Juergen Reess	31
6	P0007 Pramipexole significantly reduces periodic limb movement index (PLMI) in restless legs syndrome (RLS) 2007 ·Sleep Medicine ·(unknown), Markku Partinen, Kari Hirvonen, Anniina Alakuijala, Christer Hublin, Ilkka Tamminen, Juergen Koester	1
7	P0008 Efficacy of pramipexole by clinician and patient assessment during a polysomnographic (PSG) study of restless legs syndrome (RLS) 2007 ·Sleep Medicine ·Kari Hirvonen, Markku Partinen, (unknown), Anniina Alakuijala, Christer Hublin, Ilkka Tamminen, Juergen Koester	1
8	P0011 In patients with restless legs syndrome (RLS), pramipexole significantly improves periodic limb movements during time in bed index (PLMI) 2007 ·Sleep Medicine ·Markku Partinen, Kari Hirvonen, (unknown), Anniina Alakuijala, Christer Hublin, Ilkka Tamminen, Juergen Koester	1
9	Efficacy and safety of pramipexole in idiopathic restless legs syndrome: A polysomnographic dose-finding study—The PRELUDE study 2006 ·Sleep Medicine ·Markku Partinen, Kari Hirvonen, (unknown), Anniina Alakuijala, Christer Hublin, Ilkka Tamminen, Juergen Koester, Juergen Reess	110
10	Effects of the dopamine agonist pramipexole on depression, anhedonia and motor functioning in Parkinson's disease 2006 ·Journal of the Neurological Sciences ·Matthias Lemke, H. M. Brecht, Juergen Koester, Heinz Reichmann	105
11	Efficacy of pramipexole in restless legs syndrome: A six‐week, multicenter, randomized, double‐blind study (effect‐RLS study) 2006 ·Movement Disorders ·Wolfgang H. Oertel, Karin Stiasny‐Kolster, (unknown), Yngve Hallström, (unknown), Lena Leissner, Thomas M. Schindler, Juergen Koester, Juergen Reess	94
12	Controlled withdrawal of pramipexole after 6 months of open‐label treatment in patients with restless legs syndrome 2006 ·Movement Disorders ·Claudia Trenkwalder, Karin Stiasny‐Kolster, Andreas Kupsch, Wolfgang H. Oertel, Juergen Koester, Juergen Reess	67
13	P481 Clinician ratings and patient self-ratings of improvement after 3 weeks of double-blind placebo-controlled pramipexole for restless legs syndrome (RLS) 2006 ·Sleep Medicine ·Markku Partinen, Kari Hirvonen, (unknown), Anniina Alakuijala, Christer Hublin, Ilkka Tamminen, Juergen Koester	4
14	Efficacy and safety of pramipexole in restless legs syndrome 2006 ·Neurology ·John W. Winkelman, Kapil D. Sethi, Clete A. Kushida, Philip M. Becker, Juergen Koester, (unknown), Juergen Reess	143
15	P482 Effects of pramipexole on periodic limb movements (PLMs) in restless legs syndrome (RLS): A polysomnographic study 2006 ·Sleep Medicine ·Markku Partinen, Kari Hirvonen, (unknown), Anniina Alakuijala, Christer Hublin, Ilkka Tamminen, Juergen Koester	1
16	Anhedonia, Depression, and Motor Functioning in Parkinson’s Disease During Treatment With Pramipexole 2005 ·Journal of Neuropsychiatry ·Matthias Lemke, H. M. Brecht, Juergen Koester, Peter H. Kraus, Heinz Reichmann	112

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact